Delta, 60% more infectious

UK, Cases, + 8,125, Highest since February 26

Confirmed infections up 58.1% week on week

Deaths, + 17

70 million vaccines administered

Indian/Delta variant, doubling every 4.5 to 11.5 days in English

60% per cent more infectious than Kent/Alpha variant

5% of Indian variant infections are in the fully vaccinated

UK variants

5 April to 16 May

N = 1,054 confirmed B.1.617.2 genomic sequencing

Pfizer-BioNTech vaccine, 88% effective against symptomatic disease from B.1.617.2 variant 2 weeks after the second dose

(93% effectiveness against the B.1.1.7)

2 doses of AstraZeneca, 60% effective against symptomatic disease from the B.1.617.2

(66% effectiveness against B.1.1.7)

Both vaccines, 33% effective against symptomatic disease from B.1.617.2, 3 weeks after the first dose

(50% effectiveness against B.1.1.7)

AstraZeneca later than Pfizer-BioNTech

Immune profile develops more slowly with AZ

So far, up to 9 May

Vaccination programme has prevented 13,000

39,100 hospitalisations in older people in England.

Bolton

May, 155,016 Covid tests were carried out in Bolton - one test for every two people

Looked for reasons to vaccinate

Nadhim Zahawi

We are on track for offering all over 50s who have had the first jab their second jab by June 21

Very high levels of uptake, in the 90%s

but we have got to make sure they get their second jab

5 or 6% who didn't have their jab, please come forward

21st June

Jim McManus, vice-president of the Association of Directors of Public Health

Need an other 4 weeks

Data, and not dates

invest that little bit of time to keep us going forwards, it will stop us going backwards

The complete lifting of measures on the 21st of June not only risks an increase in cases and hospitalisation,

but risks the introduction of new variants to the UK which will undermine our vaccination programme and derail our path back to normality

UK official data